MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, CHRS has $258,343K in assets. $197,329K in debts. $88,879K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
147.24%
Quick Ratio
144.98%
Cash Ratio
63.31%
Debt to Asset Ratio
76.38%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Investments in marketable securi...
    • Trade receivables, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Tsa payables and accrued liabili...
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
88,879
Investments in marketable securities
83,246
Trade receivables, net
17,815
Tsa receivables, net
603
Inventory
3,172
Prepaid manufacturing
6,758
Other prepaids and current assets
6,233
Total current assets
206,706
Property and equipment, net
1,345
Intangible assets, net
46,239
Other assets, non-current
4,053
Total assets
258,343
Accounts payable
9,915
Accrued rebates, fees and reserves
30,397
Tsa payables and accrued liabilities
65,065
Accrued compensation
14,579
Accrued and other current liabilities
20,430
Total current liabilities
140,386
Term loan, non-current
37,051
Lease liabilities, non-current
1,457
Other liabilities, non-current
18,435
Total liabilities
197,329
Common stock (0.0001 par value shares authorized 300,000,000 shares issued and outstanding 121,154,925 and 115,614,548 at december 31, 2025 and december 31, 2024, respectively)
12
Additional paid-in capital
1,444,166
Accumulated other comprehensive loss
-195
Accumulated deficit
-1,382,969
Total stockholders' equity (deficit)
61,014
Total liabilities and stockholders' equity (deficit)
258,343
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$88,879K Investments in marketablesecurities$83,246K Trade receivables,net$17,815K Prepaid manufacturing$6,758K Other prepaids andcurrent assets$6,233K Inventory$3,172K Tsa receivables,net$603K Total current assets$206,706K Intangible assets, net$46,239K Other assets,non-current$4,053K Property and equipment,net$1,345K Total assets$258,343K Total liabilities andstockholders' equity...$258,343K Total liabilities$197,329K Total stockholders'equity (deficit)$61,014K Accumulated deficit-$1,382,969K Accumulated othercomprehensive loss-$195K Total currentliabilities$140,386K Term loan,non-current$37,051K Other liabilities,non-current$18,435K Lease liabilities,non-current$1,457K Additional paid-in capital$1,444,166K Common stock (0.0001par value shares...$12K Tsa payables andaccrued liabilities$65,065K Accrued rebates, feesand reserves$30,397K Accrued and othercurrent liabilities$20,430K Accrued compensation$14,579K Accounts payable$9,915K

Coherus Oncology, Inc. (CHRS)

Coherus Oncology, Inc. (CHRS)